JCR Pharmaceuticals' Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders | Region

HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--

Related Keywords

Eppendorf ,Nordrhein Westfalen ,Germany ,Kyoto ,Japan ,Rio Grande Do Sul ,Brazil ,Kanagawa ,Fukushima ,San Diego ,California ,United States ,Hyogo ,Hokkaido ,Sao Paulo ,Sãpaulo ,Hamburg ,Canada ,Brazilian ,Japanese ,America ,Nicole Muschol ,Atsushi Imakiire ,Roberto Giugliani ,Hiroki Morioka ,Toshiaki Ikeda ,Porto Alegre ,Shin Ashida ,Bayley Scale For Infant Development ,Phd Institute Of Neurological Disorders ,Ministry Of Health ,Platform Technology ,Clinical Research Center ,Md University Medical Center Hamburg ,International Center ,Ana Maria Martins Reference Center ,Corporate Communications ,Institute Of Neurological Disorders ,Pharmaceuticals Co Ltd ,Kyoto Scale Of Psychological Development ,University Of Sao Paulo ,J Brain Cargo ,Yoshikatsu Eto ,Neurological Disorders ,Advanced Clinical Research Center ,Kyoto Scale ,Psychological Development ,Bayley Scale ,Infant Development ,Kaufman Assessment Battery ,Vineland Adaptive Behavioral Scale ,Federal University ,Rio Grande ,Ana Maria Martins ,Reference Center ,Inborn Errors ,University Medical Center Hamburg Eppendorf ,Lysosomal Disorders ,Pabinafusp Alfa ,Hunter Syndrome ,Sanfilippo Syndrome ,Anti Human Transferrin Receptor Antibody ,Neuropathic Mucopolysaccharidosis ,Targeting Neurodegeneration ,Replacement Therapy ,Integrated Analysis ,Business Wire ,Region ,